Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere Disease

Background: Meniere disease (MD) is an inner ear disorder associated with comorbidities such as autoimmune diseases or migraine. This study describes clinical and cytokine profiles in MD according to the age of onset of the condition. Methods: A cross-sectional study including 83 MD patients: 44 wit...

Full description

Bibliographic Details
Main Authors: Maria-Del-Carmen Moleon, Estrella Martinez-Gomez, Marisa Flook, Andreina Peralta-Leal, Juan Antonio Gallego, Hortensia Sanchez-Gomez, Maria Alharilla Montilla-Ibañez, Emilio Dominguez-Durán, Andres Soto-Varela, Ismael Aran, Lidia Frejo, Jose A. Lopez-Escamez
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/18/4052
_version_ 1797518766579384320
author Maria-Del-Carmen Moleon
Estrella Martinez-Gomez
Marisa Flook
Andreina Peralta-Leal
Juan Antonio Gallego
Hortensia Sanchez-Gomez
Maria Alharilla Montilla-Ibañez
Emilio Dominguez-Durán
Andres Soto-Varela
Ismael Aran
Lidia Frejo
Jose A. Lopez-Escamez
author_facet Maria-Del-Carmen Moleon
Estrella Martinez-Gomez
Marisa Flook
Andreina Peralta-Leal
Juan Antonio Gallego
Hortensia Sanchez-Gomez
Maria Alharilla Montilla-Ibañez
Emilio Dominguez-Durán
Andres Soto-Varela
Ismael Aran
Lidia Frejo
Jose A. Lopez-Escamez
author_sort Maria-Del-Carmen Moleon
collection DOAJ
description Background: Meniere disease (MD) is an inner ear disorder associated with comorbidities such as autoimmune diseases or migraine. This study describes clinical and cytokine profiles in MD according to the age of onset of the condition. Methods: A cross-sectional study including 83 MD patients: 44 with early-onset MD (EOMD, <35 years old), and 39 with late-onset MD (LOMD, >50 years old), 64 patients with migraine and 55 controls was carried out. Clinical variables and cytokines levels of CCL3, CCL4, CCL18, CCL22, CXCL,1 and IL-1β were compared among the different groups. Results: CCL18 levels were higher in patients with migraine or MD than in controls. Elevated levels of IL-1β were observed in 11.4% EOMD and in 10.3% LOMD patients and these levels were not dependent on the age of individuals. EOMD had a longer duration of the disease (<i>p</i> = 0.004) and a higher prevalence of migraine than LOMD (<i>p</i> = 0.045). Conclusions: Patients with EOMD have a higher prevalence of migraine than LOMD, but migraine is not associated with any cytokine profile in patients with MD. The levels of CCL18, CCL3, and CXCL4 were different between patients with MD or migraine and controls.
first_indexed 2024-03-10T07:34:14Z
format Article
id doaj.art-cc3b7fd9d84b4eda9cd14dc1555159e2
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T07:34:14Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-cc3b7fd9d84b4eda9cd14dc1555159e22023-11-22T13:38:44ZengMDPI AGJournal of Clinical Medicine2077-03832021-09-011018405210.3390/jcm10184052Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere DiseaseMaria-Del-Carmen Moleon0Estrella Martinez-Gomez1Marisa Flook2Andreina Peralta-Leal3Juan Antonio Gallego4Hortensia Sanchez-Gomez5Maria Alharilla Montilla-Ibañez6Emilio Dominguez-Durán7Andres Soto-Varela8Ismael Aran9Lidia Frejo10Jose A. Lopez-Escamez11Otology and Neurotology Group CTS495, Department of Genomic Medicine, GENYO—Centre for Genomics and Oncological Research—Pfizer/University of Granada/Junta de Andalucía, PTS, 18016 Granada, SpainOtology and Neurotology Group CTS495, Department of Genomic Medicine, GENYO—Centre for Genomics and Oncological Research—Pfizer/University of Granada/Junta de Andalucía, PTS, 18016 Granada, SpainOtology and Neurotology Group CTS495, Department of Genomic Medicine, GENYO—Centre for Genomics and Oncological Research—Pfizer/University of Granada/Junta de Andalucía, PTS, 18016 Granada, SpainOtology and Neurotology Group CTS495, Department of Genomic Medicine, GENYO—Centre for Genomics and Oncological Research—Pfizer/University of Granada/Junta de Andalucía, PTS, 18016 Granada, SpainDepartment of Neurology, Hospital Universitario Virgen de las Nieves, Universidad de Granada, 18014 Granada, SpainOtoneurology Unit, Department of Otorhinolaryngology, University Hospital of Salamanca, IBSAL, 37007 Salamanca, SpainDepartment of Otorhinolaryngology, Complejo Hospitalario de Jaén, 23007 Jaen, SpainDepartment of Otolaryngology, Hospital Virgen Macarena, 41009 Sevilla, SpainDivision of Neurotology, Department of Otorhinolaryngology, Complexo Hospitalario Universitario, 15706 Santiago de Compostela, SpainDepartment of Otolaryngology, Complexo Hospitalario de Pontevedra, 36071 Pontevedra, SpainOtology and Neurotology Group CTS495, Department of Genomic Medicine, GENYO—Centre for Genomics and Oncological Research—Pfizer/University of Granada/Junta de Andalucía, PTS, 18016 Granada, SpainOtology and Neurotology Group CTS495, Department of Genomic Medicine, GENYO—Centre for Genomics and Oncological Research—Pfizer/University of Granada/Junta de Andalucía, PTS, 18016 Granada, SpainBackground: Meniere disease (MD) is an inner ear disorder associated with comorbidities such as autoimmune diseases or migraine. This study describes clinical and cytokine profiles in MD according to the age of onset of the condition. Methods: A cross-sectional study including 83 MD patients: 44 with early-onset MD (EOMD, <35 years old), and 39 with late-onset MD (LOMD, >50 years old), 64 patients with migraine and 55 controls was carried out. Clinical variables and cytokines levels of CCL3, CCL4, CCL18, CCL22, CXCL,1 and IL-1β were compared among the different groups. Results: CCL18 levels were higher in patients with migraine or MD than in controls. Elevated levels of IL-1β were observed in 11.4% EOMD and in 10.3% LOMD patients and these levels were not dependent on the age of individuals. EOMD had a longer duration of the disease (<i>p</i> = 0.004) and a higher prevalence of migraine than LOMD (<i>p</i> = 0.045). Conclusions: Patients with EOMD have a higher prevalence of migraine than LOMD, but migraine is not associated with any cytokine profile in patients with MD. The levels of CCL18, CCL3, and CXCL4 were different between patients with MD or migraine and controls.https://www.mdpi.com/2077-0383/10/18/4052hearing lossvertigomigrainecytokinesinflammationvestibular disorders
spellingShingle Maria-Del-Carmen Moleon
Estrella Martinez-Gomez
Marisa Flook
Andreina Peralta-Leal
Juan Antonio Gallego
Hortensia Sanchez-Gomez
Maria Alharilla Montilla-Ibañez
Emilio Dominguez-Durán
Andres Soto-Varela
Ismael Aran
Lidia Frejo
Jose A. Lopez-Escamez
Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere Disease
Journal of Clinical Medicine
hearing loss
vertigo
migraine
cytokines
inflammation
vestibular disorders
title Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere Disease
title_full Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere Disease
title_fullStr Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere Disease
title_full_unstemmed Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere Disease
title_short Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere Disease
title_sort clinical and cytokine profile in patients with early and late onset meniere disease
topic hearing loss
vertigo
migraine
cytokines
inflammation
vestibular disorders
url https://www.mdpi.com/2077-0383/10/18/4052
work_keys_str_mv AT mariadelcarmenmoleon clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT estrellamartinezgomez clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT marisaflook clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT andreinaperaltaleal clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT juanantoniogallego clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT hortensiasanchezgomez clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT mariaalharillamontillaibanez clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT emiliodominguezduran clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT andressotovarela clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT ismaelaran clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT lidiafrejo clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease
AT josealopezescamez clinicalandcytokineprofileinpatientswithearlyandlateonsetmenieredisease